United States Male Hypogonadism Market Report 2017

August 2017 | 108 pages | ID: UD5A5430682EN
QYResearch

Abstracts

In this report, the United States Male Hypogonadism market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Male Hypogonadism in these regions, from 2012 to 2022 (forecast).

United States Male Hypogonadism market competition by top manufacturers/players, with Male Hypogonadism sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Astrazeneca Plc.
• Merck & Co. Inc.
• Laboratories Genevrier
• Allergan Plc.
• Endo International Plc.
• Ferring
• AbbVie Inc.
• Eli Lilly and Company Ltd.
• Finox Biotech
• Teva Pharmaceutical Industries Ltd.
• Bayer AG
• IBSA Institut Biochimque

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Testosterone Replacement Therapy
• Gonadotropin-Releasing Hormones Therapy

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Male Hypogonadism for each application, including

• Kallmann Syndrome
• Klinefelters Syndrome
• Pituitary Disorders
• Others

Contents

United States Male Hypogonadism Market Report 2017

1 MALE HYPOGONADISM OVERVIEW

1.1 Product Overview and Scope of Male Hypogonadism
1.2 Classification of Male Hypogonadism by Product Category
  1.2.1 United States Male Hypogonadism Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Male Hypogonadism Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Testosterone Replacement Therapy
  1.2.4 Gonadotropin-Releasing Hormones Therapy
1.3 United States Male Hypogonadism Market by Application/End Users
  1.3.1 United States Male Hypogonadism Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Kallmann Syndrome
  1.3.3 Klinefelters Syndrome
  1.3.4 Pituitary Disorders
  1.3.5 Others
1.4 United States Male Hypogonadism Market by Region
  1.4.1 United States Male Hypogonadism Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Male Hypogonadism Status and Prospect (2012-2022)
  1.4.3 Southwest Male Hypogonadism Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Male Hypogonadism Status and Prospect (2012-2022)
  1.4.5 New England Male Hypogonadism Status and Prospect (2012-2022)
  1.4.6 The South Male Hypogonadism Status and Prospect (2012-2022)
  1.4.7 The Midwest Male Hypogonadism Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Male Hypogonadism (2012-2022)
  1.5.1 United States Male Hypogonadism Sales and Growth Rate (2012-2022)
  1.5.2 United States Male Hypogonadism Revenue and Growth Rate (2012-2022)

2 UNITED STATES MALE HYPOGONADISM MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Male Hypogonadism Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Male Hypogonadism Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Male Hypogonadism Average Price by Players/Suppliers (2012-2017)
2.4 United States Male Hypogonadism Market Competitive Situation and Trends
  2.4.1 United States Male Hypogonadism Market Concentration Rate
  2.4.2 United States Male Hypogonadism Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Male Hypogonadism Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES MALE HYPOGONADISM SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Male Hypogonadism Sales and Market Share by Region (2012-2017)
3.2 United States Male Hypogonadism Revenue and Market Share by Region (2012-2017)
3.3 United States Male Hypogonadism Price by Region (2012-2017)

4 UNITED STATES MALE HYPOGONADISM SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Male Hypogonadism Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Male Hypogonadism Revenue and Market Share by Type (2012-2017)
4.3 United States Male Hypogonadism Price by Type (2012-2017)
4.4 United States Male Hypogonadism Sales Growth Rate by Type (2012-2017)

5 UNITED STATES MALE HYPOGONADISM SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Male Hypogonadism Sales and Market Share by Application (2012-2017)
5.2 United States Male Hypogonadism Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES MALE HYPOGONADISM PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Astrazeneca Plc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Male Hypogonadism Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Astrazeneca Plc. Male Hypogonadism Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Merck & Co. Inc.
  6.2.2 Male Hypogonadism Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Merck & Co. Inc. Male Hypogonadism Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Laboratories Genevrier
  6.3.2 Male Hypogonadism Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Laboratories Genevrier Male Hypogonadism Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Allergan Plc.
  6.4.2 Male Hypogonadism Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Allergan Plc. Male Hypogonadism Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Endo International Plc.
  6.5.2 Male Hypogonadism Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Endo International Plc. Male Hypogonadism Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Ferring
  6.6.2 Male Hypogonadism Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Ferring Male Hypogonadism Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 AbbVie Inc.
  6.7.2 Male Hypogonadism Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 AbbVie Inc. Male Hypogonadism Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Eli Lilly and Company Ltd.
  6.8.2 Male Hypogonadism Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Eli Lilly and Company Ltd. Male Hypogonadism Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Finox Biotech
  6.9.2 Male Hypogonadism Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Finox Biotech Male Hypogonadism Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Teva Pharmaceutical Industries Ltd.
  6.10.2 Male Hypogonadism Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Teva Pharmaceutical Industries Ltd. Male Hypogonadism Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Bayer AG
6.12 IBSA Institut Biochimque

7 MALE HYPOGONADISM MANUFACTURING COST ANALYSIS

7.1 Male Hypogonadism Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Male Hypogonadism

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Male Hypogonadism Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Male Hypogonadism Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES MALE HYPOGONADISM MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Male Hypogonadism Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Male Hypogonadism Sales Volume Forecast by Type (2017-2022)
11.3 United States Male Hypogonadism Sales Volume Forecast by Application (2017-2022)
11.4 United States Male Hypogonadism Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Male Hypogonadism
Figure United States Male Hypogonadism Market Size (K Units) by Type (2012-2022)
Figure United States Male Hypogonadism Sales Volume Market Share by Type (Product Category) in 2016
Figure Testosterone Replacement Therapy Product Picture
Figure Gonadotropin-Releasing Hormones Therapy Product Picture
Figure United States Male Hypogonadism Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Male Hypogonadism by Application in 2016
Figure Kallmann Syndrome Examples
Figure Klinefelters Syndrome Examples
Figure Pituitary Disorders Examples
Figure Others Examples
Figure United States Male Hypogonadism Market Size (Million USD) by Region (2012-2022)
Figure The West Male Hypogonadism Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Male Hypogonadism Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Male Hypogonadism Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Male Hypogonadism Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Male Hypogonadism Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Male Hypogonadism Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Male Hypogonadism Sales (K Units) and Growth Rate (2012-2022)
Figure United States Male Hypogonadism Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Male Hypogonadism Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Male Hypogonadism Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Male Hypogonadism Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Male Hypogonadism Sales Share by Players/Suppliers
Figure 2017 United States Male Hypogonadism Sales Share by Players/Suppliers
Figure United States Male Hypogonadism Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Male Hypogonadism Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Male Hypogonadism Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Male Hypogonadism Revenue Share by Players/Suppliers
Figure 2017 United States Male Hypogonadism Revenue Share by Players/Suppliers
Table United States Market Male Hypogonadism Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Male Hypogonadism Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Male Hypogonadism Market Share of Top 3 Players/Suppliers
Figure United States Male Hypogonadism Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Male Hypogonadism Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Male Hypogonadism Product Category
Table United States Male Hypogonadism Sales (K Units) by Region (2012-2017)
Table United States Male Hypogonadism Sales Share by Region (2012-2017)
Figure United States Male Hypogonadism Sales Share by Region (2012-2017)
Figure United States Male Hypogonadism Sales Market Share by Region in 2016
Table United States Male Hypogonadism Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Male Hypogonadism Revenue Share by Region (2012-2017)
Figure United States Male Hypogonadism Revenue Market Share by Region (2012-2017)
Figure United States Male Hypogonadism Revenue Market Share by Region in 2016
Table United States Male Hypogonadism Price (USD/Unit) by Region (2012-2017)
Table United States Male Hypogonadism Sales (K Units) by Type (2012-2017)
Table United States Male Hypogonadism Sales Share by Type (2012-2017)
Figure United States Male Hypogonadism Sales Share by Type (2012-2017)
Figure United States Male Hypogonadism Sales Market Share by Type in 2016
Table United States Male Hypogonadism Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Male Hypogonadism Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Male Hypogonadism by Type (2012-2017)
Figure Revenue Market Share of Male Hypogonadism by Type in 2016
Table United States Male Hypogonadism Price (USD/Unit) by Types (2012-2017)
Figure United States Male Hypogonadism Sales Growth Rate by Type (2012-2017)
Table United States Male Hypogonadism Sales (K Units) by Application (2012-2017)
Table United States Male Hypogonadism Sales Market Share by Application (2012-2017)
Figure United States Male Hypogonadism Sales Market Share by Application (2012-2017)
Figure United States Male Hypogonadism Sales Market Share by Application in 2016
Table United States Male Hypogonadism Sales Growth Rate by Application (2012-2017)
Figure United States Male Hypogonadism Sales Growth Rate by Application (2012-2017)
Table Astrazeneca Plc. Basic Information List
Table Astrazeneca Plc. Male Hypogonadism Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Astrazeneca Plc. Male Hypogonadism Sales Growth Rate (2012-2017)
Figure Astrazeneca Plc. Male Hypogonadism Sales Market Share in United States (2012-2017)
Figure Astrazeneca Plc. Male Hypogonadism Revenue Market Share in United States (2012-2017)
Table Merck & Co. Inc. Basic Information List
Table Merck & Co. Inc. Male Hypogonadism Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co. Inc. Male Hypogonadism Sales Growth Rate (2012-2017)
Figure Merck & Co. Inc. Male Hypogonadism Sales Market Share in United States (2012-2017)
Figure Merck & Co. Inc. Male Hypogonadism Revenue Market Share in United States (2012-2017)
Table Laboratories Genevrier Basic Information List
Table Laboratories Genevrier Male Hypogonadism Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Laboratories Genevrier Male Hypogonadism Sales Growth Rate (2012-2017)
Figure Laboratories Genevrier Male Hypogonadism Sales Market Share in United States (2012-2017)
Figure Laboratories Genevrier Male Hypogonadism Revenue Market Share in United States (2012-2017)
Table Allergan Plc. Basic Information List
Table Allergan Plc. Male Hypogonadism Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Allergan Plc. Male Hypogonadism Sales Growth Rate (2012-2017)
Figure Allergan Plc. Male Hypogonadism Sales Market Share in United States (2012-2017)
Figure Allergan Plc. Male Hypogonadism Revenue Market Share in United States (2012-2017)
Table Endo International Plc. Basic Information List
Table Endo International Plc. Male Hypogonadism Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Endo International Plc. Male Hypogonadism Sales Growth Rate (2012-2017)
Figure Endo International Plc. Male Hypogonadism Sales Market Share in United States (2012-2017)
Figure Endo International Plc. Male Hypogonadism Revenue Market Share in United States (2012-2017)
Table Ferring Basic Information List
Table Ferring Male Hypogonadism Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Ferring Male Hypogonadism Sales Growth Rate (2012-2017)
Figure Ferring Male Hypogonadism Sales Market Share in United States (2012-2017)
Figure Ferring Male Hypogonadism Revenue Market Share in United States (2012-2017)
Table AbbVie Inc. Basic Information List
Table AbbVie Inc. Male Hypogonadism Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AbbVie Inc. Male Hypogonadism Sales Growth Rate (2012-2017)
Figure AbbVie Inc. Male Hypogonadism Sales Market Share in United States (2012-2017)
Figure AbbVie Inc. Male Hypogonadism Revenue Market Share in United States (2012-2017)
Table Eli Lilly and Company Ltd. Basic Information List
Table Eli Lilly and Company Ltd. Male Hypogonadism Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Ltd. Male Hypogonadism Sales Growth Rate (2012-2017)
Figure Eli Lilly and Company Ltd. Male Hypogonadism Sales Market Share in United States (2012-2017)
Figure Eli Lilly and Company Ltd. Male Hypogonadism Revenue Market Share in United States (2012-2017)
Table Finox Biotech Basic Information List
Table Finox Biotech Male Hypogonadism Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Finox Biotech Male Hypogonadism Sales Growth Rate (2012-2017)
Figure Finox Biotech Male Hypogonadism Sales Market Share in United States (2012-2017)
Figure Finox Biotech Male Hypogonadism Revenue Market Share in United States (2012-2017)
Table Teva Pharmaceutical Industries Ltd. Basic Information List
Table Teva Pharmaceutical Industries Ltd. Male Hypogonadism Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Industries Ltd. Male Hypogonadism Sales Growth Rate (2012-2017)
Figure Teva Pharmaceutical Industries Ltd. Male Hypogonadism Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceutical Industries Ltd. Male Hypogonadism Revenue Market Share in United States (2012-2017)
Table Bayer AG Basic Information List
Table IBSA Institut Biochimque Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Male Hypogonadism
Figure Manufacturing Process Analysis of Male Hypogonadism
Figure Male Hypogonadism Industrial Chain Analysis
Table Raw Materials Sources of Male Hypogonadism Major Players/Suppliers in 2016
Table Major Buyers of Male Hypogonadism
Table Distributors/Traders List
Figure United States Male Hypogonadism Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Male Hypogonadism Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Male Hypogonadism Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Male Hypogonadism Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Male Hypogonadism Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Male Hypogonadism Sales Volume (K Units) Forecast by Type in 2022
Table United States Male Hypogonadism Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Male Hypogonadism Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Male Hypogonadism Sales Volume (K Units) Forecast by Application in 2022
Table United States Male Hypogonadism Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Male Hypogonadism Sales Volume Share Forecast by Region (2017-2022)
Figure United States Male Hypogonadism Sales Volume Share Forecast by Region (2017-2022)
Figure United States Male Hypogonadism Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources